| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $4.13 (Beat by $0.46) |
| EPS GAAP Actual | $4.13 (Beat by $0.46) |
| Revenue Actual | $77.673B |
| Revenue Surprise | Beat by $77673M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 0 | INF | 0 | 0 | 8 |
| Jun 2029 | 24.235 | 18.98 | 23.20873 | 25.60393 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.73 | 3.73 | 77.673B | 15.56% | 77673M |
| FQ2 2025 (Jun 2025) | 3.67 | 3.67 | 76.441B | 15.32% | 76441M |
| FQ1 2025 (Mar 2025) | 3.47 | 3.47 | 70.066B | 11.71% | 70066M |
| FQ4 2024 (Dec 2024) | 3.24 | 3.24 | 69.632B | 10.93% | 69632M |
| FQ3 2024 (Sep 2024) | 3.3 | 3.3 | 65.585B | 13.83% | 65585M |
| FQ2 2024 (Jun 2024) | 2.96 | 2.96 | 64.727B | 13.19% | 64727M |
| FQ1 2024 (Mar 2024) | 2.95 | 2.95 | 61.858B | 14.55% | 61858M |
| FQ4 2023 (Dec 2023) | 2.94 | 2.94 | 62.02B | 14.95% | 62020M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 5.80817 | -- | 5.6462 | 5.94771 | 12 |
| FQ1 2028 (Mar 2028) | 5.41298 | -- | 5.26203 | 5.54303 | 11 |
| FQ4 2027 (Dec 2027) | 5.28046 | -- | 5.13321 | 5.40733 | 18 |
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 8 |
| FQ2 2027 (Jun 2027) | 4.92403 | -- | 4.78672 | 5.04233 | 16 |
| FQ1 2027 (Mar 2027) | 4.61377 | -- | 4.48511 | 4.72462 | 15 |
| FQ4 2026 (Dec 2026) | 4.53407 | -- | 4.40763 | 4.643 | 10 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 115.13B | -- | 112.66B | 117.26B | 12 |
| FQ1 2028 (Mar 2028) | 107.25B | -- | 104.95B | 109.23B | 17 |
| FQ4 2027 (Dec 2027) | 106.39B | -- | 104.11B | 108.36B | 18 |
| FQ3 2027 (Jul 2027) | 95.68B | -- | 93.83B | 96.93B | 9 |
| FQ2 2027 (Jun 2027) | 100.8B | -- | 98.64B | 102.67B | 16 |
| FQ1 2027 (Mar 2027) | 93.56B | -- | 91.56B | 95.29B | 13 |
| FQ4 2026 (Dec 2026) | 92.2B | -- | 90.22B | 93.9B | 13 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.73 | 3.73 | 100% | |
| FQ2 2025 (Jun 2025) | 3.67 | 3.67 | 100% | |
| FQ1 2025 (Mar 2025) | 3.47 | 3.47 | 100% | |
| FQ4 2024 (Dec 2024) | 3.24 | 3.24 | 100% | |
| FQ3 2024 (Sep 2024) | 3.3 | 3.3 | 100% | |
| FQ2 2024 (Jun 2024) | 2.96 | 2.96 | 100% | |
| FQ1 2024 (Mar 2024) | 2.95 | 2.95 | 100% | |
| FQ4 2023 (Dec 2023) | 2.94 | 2.94 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $77.67B | $77673M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $76.44B | $76441M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $70.07B | $70066M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $69.63B | $69632M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $65.59B | $65585M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $64.73B | $64727M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $61.86B | $61858M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $62.02B | $62020M | 100% |